Zymeworks Inc. Common Stock is a biopharmaceutical company that specializes in the development of innovative protein therapeutics for the treatment of cancer and other diseases. Their proprietary platform enables the design and engineering of highly specific and effective therapeutic antibodies, offering promising solutions in the field of precision medicine.
